Variant report
Variant | esv3463178 |
---|---|
Chromosome Location | chr3:195653383-195653940 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195637314..195639041-chr3:195651687..195654155,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000226155 | chromatin interactions |
ENSG00000061938 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554936043 | chr3:195653401-195653402 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs573729232 | chr3:195653470-195653471 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs73208018 | chr3:195653472-195653473 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs192694022 | chr3:195653510-195653511 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs533326810 | chr3:195653519-195653520 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs58759805 | chr3:195653525-195653526 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs75992976 | chr3:195653526-195653527 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs78571898 | chr3:195653543-195653544 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs79774115 | chr3:195653546-195653547 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs397876878 | chr3:195653547-195653548 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs113755682 | chr3:195653553-195653554 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs545736027 | chr3:195653560-195653561 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs112033665 | chr3:195653564-195653565 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs183217663 | chr3:195653592-195653593 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs530938034 | chr3:195653603-195653604 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs549439185 | chr3:195653617-195653618 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs572812238 | chr3:195653621-195653622 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs528620938 | chr3:195653622-195653623 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs541677792 | chr3:195653623-195653624 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs565889948 | chr3:195653630-195653631 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs376708276 | chr3:195653631-195653632 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs539211840 | chr3:195653637-195653638 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs371329582 | chr3:195653641-195653642 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs557642891 | chr3:195653655-195653656 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs549947656 | chr3:195653656-195653657 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs565154545 | chr3:195653667-195653668 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs112640524 | chr3:195653673-195653674 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs532836563 | chr3:195653678-195653679 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs112028360 | chr3:195653681-195653682 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs551066102 | chr3:195653686-195653687 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs386670110 | chr3:195653691-195653692 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs572239009 | chr3:195653697-195653698 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs569658704 | chr3:195653702-195653703 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs113592852 | chr3:195653714-195653715 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs370468598 | chr3:195653731-195653732 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs536946920 | chr3:195653740-195653741 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs374728465 | chr3:195653746-195653747 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs188078256 | chr3:195653750-195653751 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs112376541 | chr3:195653765-195653766 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs566424524 | chr3:195653772-195653773 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs112375159 | chr3:195653776-195653777 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs533547811 | chr3:195653809-195653810 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs6786626 | chr3:195653810-195653811 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs578125653 | chr3:195653820-195653821 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs545577009 | chr3:195653821-195653822 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs73208019 | chr3:195653824-195653825 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs531276690 | chr3:195653871-195653872 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs9861325 | chr3:195653873-195653874 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs112503834 | chr3:195653899-195653900 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs146429713 | chr3:195653927-195653928 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:195642000-195656600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:195645600-195658800 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr3:195647200-195681200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr3:195648600-195660400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr3:195648600-195666600 | Weak transcription | Lung | lung |
6 | chr3:195648600-195666600 | Weak transcription | Spleen | Spleen |
7 | chr3:195648600-195680600 | Weak transcription | Pancreas | Pancrea |
8 | chr3:195648800-195658200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr3:195648800-195666600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr3:195648800-195666800 | Weak transcription | Esophagus | oesophagus |
11 | chr3:195649000-195655400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr3:195649800-195659200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr3:195651200-195656600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr3:195651200-195658200 | Weak transcription | Brain Hippocampus Middle | brain |
15 | chr3:195651200-195671200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
16 | chr3:195651800-195673800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr3:195652600-195655400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
18 | chr3:195652800-195656400 | Weak transcription | HepG2 | liver |
19 | chr3:195653000-195658400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
20 | chr3:195653000-195666800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |